[Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic].

O O Ianushevich Igor MaevN I KrikheliOleg V Levchenko I V Rogova A V Zaborovsky Dmitrii N Andreev A L Kebina Dmitry S BordinI G BakulinNatalia Bakulina N G Andreev P O Asadulin A S Bagdasarian M K Devkota N R Evarnitskaia O V Krikunova S A Kucher Filipp S Sokolov Aleksey K Fomenko V A Khar'kovskii I A Sharina

Published in: Terapevticheskii arkhiv (2021)

The present study has demonstrated that gastroenterological symptoms are detected in about one in four patients infected with the SARS-CoV-2 virus and multiply the risk of adverse and life-threatening complications of COVID-19.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
risk factors
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
primary care
emergency department
big data
physical activity
depressive symptoms
machine learning
adverse drug
drug induced